Profile
Catherine Mathis served as Director of Regulatory Affairs at Transgene SA from 1994 to 2014.
She then worked as Senior Director of Regulatory Affairs at Voisin Consulting, Inc. in 2014-2015.
In 2016, she became Vice President of Regulatory Affairs at Sangamo Therapeutics France SAS, and later that year, she became the Chief Operating Officer at ElsaLys Biotech SAS, where she worked until 2019.
Dr. Mathis holds a graduate degree from Université Paris 1 Panthéon-Sorbonne and a doctorate from Université de Paris 5 René Descartes.
Former positions of Catherine Mathis
| Companies | Position | End |
|---|---|---|
| ELSALYS BIOTECH | Chief Operating Officer | 01/02/2019 |
| TXCELL | General Counsel | 01/09/2016 |
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development consulting services | General Counsel | 01/12/2015 |
| TRANSGENE | General Counsel | 01/10/2014 |
Training of Catherine Mathis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Université Paris 1 Panthéon-Sorbonne
Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sangamo Therapeutics France SAS
Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
Université de Paris 5 René Descartes
Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ElsaLys Biotech SAS
ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology Designs, develops and supplies antibodies to modulate the immune system of patients | Health Technology |
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development consulting services | Commercial Services |
- Stock Market
- Insiders
- Catherine Mathis
















